AEON Biopharma (NASDAQ:AEON) Shares Gap Down to $14.40

AEON Biopharma, Inc. (NASDAQ:AEON)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $14.40, but opened at $13.82. AEON Biopharma shares last traded at $13.96, with a volume of 8,209 shares changing hands.

AEON Biopharma Stock Down 13.4 %

The company’s fifty day simple moving average is $10.26 and its 200-day simple moving average is $7.32.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Atalaya Capital Management LP bought a new stake in shares of AEON Biopharma in the 3rd quarter valued at approximately $19,827,000. Formidable Asset Management LLC bought a new stake in AEON Biopharma during the 3rd quarter worth about $360,000. Vanguard Group Inc. bought a new stake in shares of AEON Biopharma during the third quarter valued at approximately $1,085,000. Finally, Northern Trust Corp lifted its holdings in AEON Biopharma by 53.4% during the 4th quarter. Northern Trust Corp now owns 49,819 shares of the company’s stock worth $359,000 after buying an additional 17,341 shares in the last quarter.

AEON Biopharma Company Profile

AEON Biopharma, Inc, a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine.